SII Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-23,028
Closed -$1.18M 150
2017
Q4
$1.18M Sell
23,028
-3,957
-15% -$203K 0.12% 133
2017
Q3
$1.42M Buy
26,985
+1,077
+4% +$55.3K 0.08% 186
2017
Q2
$1.36M Sell
25,908
-498
-2% -$25.2K 0.08% 185
2017
Q1
$1.33M Sell
26,406
-1,263
-5% -$62.5K 0.09% 170
2016
Q4
$1.3M Sell
27,669
-129
-0.5% -$6.12K 0.1% 162
2016
Q3
$1.38M Sell
27,798
-147
-0.5% -$7.46K 0.11% 148
2016
Q2
$1.32M Buy
27,945
+2,952
+12% +$140K 0.11% 163
2016
Q1
$1.16M Buy
24,993
+300
+1% +$14K 0.11% 175
2015
Q4
$1.32M Sell
24,693
-540
-2% -$28.4K 0.17% 118
2015
Q3
$1.25M Buy
25,233
+6,738
+36% +$386K 0.14% 146
2015
Q2
$1.08M Buy
18,495
+1,617
+10% +$94.5K 0.13% 157
2015
Q1
$984K Buy
16,878
+4,803
+40% +$263K 0.12% 180
2014
Q4
$625K Buy
+12,075
New +$588K 0.08% 223
2014
Q3
Sell
-24,825
Closed -$1.15M 513
2014
Q2
$1.15M Buy
24,825
+2,325
+10% +$100K 0.16% 144
2014
Q1
$900K Buy
22,500
+1,950
+9% +$81.8K 0.17% 148
2013
Q4
$821K Hold
20,550
0.15% 166
2013
Q3
$745K Buy
20,550
+600
+3% +$21.1K 0.18% 143
2013
Q2
$665K Buy
+19,950
New +$663K 0.14% 172

Other funds holding IHE

SII Investments's IHE Position: Q1 2018 in Review

SII Investments sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2018, closing a stake of 23,028 shares — an estimated $1.18M sold.

SII Investments first reported a position in IHE in Q2 2013 and held it in 18 quarters. The position peaked at $1.42M in Q3 2017. 101 funds tracked by Wall St. Rank hold IHE as of Q1 2018.

  • SII Investments reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
  • SII Investments sold 23,028 iShares US Pharmaceuticals ETF shares in Q1 2018, an estimated $1.18M.
  • SII Investments first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 18 quarters.
  • SII Investments's iShares US Pharmaceuticals ETF position peaked at $1.42M in Q3 2017.
  • 101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2018.

Based on SII Investments's 13F filing for Q1 2018.